Start free
← Back to Current Affairs
Current Affairs · 22 November 2026

India Crosses 1 Crore HPV Vaccination Doses Under National HPV Vaccination Campaign

UPSCPIBSource: PIB
1

Why in News

  • India has administered more than 1 crore doses of the HPV vaccine under the National HPV Vaccination Campaign in less than nine months of its launch.
  • The campaign was launched by Prime Minister Shri Narendra Modi in February 2026 to prevent cervical cancer among adolescent girls.
  • It provides free, safe and voluntary single-dose HPV vaccination, with parental consent, to 14-year-old girls at Government health facilities.
  • The campaign has reached nearly 87% cumulative coverage against an annual target cohort of about 1.2 crore girls, based on RGI 2021 population estimates.
  • Six States — Gujarat, Uttar Pradesh, Andhra Pradesh, Mizoram, Madhya Pradesh and Bihar — have achieved 100% coverage of their identified target populations.
2

What is the issue

  • Cervical cancer burden: Cervical cancer remains a significant public health concern and an important cause of cancer-related illness and mortality among women in India.
  • Scientific basis: Persistent infection with certain high-risk types of Human Papillomavirus is responsible for the vast majority of cervical cancer cases.
  • Prevention over cure: HPV vaccination is among the most effective preventive interventions available to reduce the risk of HPV infections that can lead to cervical cancer.
  • Timing of protection: Vaccinating girls at 14 years seeks to offer protection well before potential exposure to HPV, contributing to long-term prevention.
  • Equity dimension: The campaign offers free vaccination at Government health facilities, aiming at equitable access across rural, urban, remote and geographically challenging areas.
  • Consent and confidence: The programme rests on informed parental consent, transparent communication and science-based information to counter misinformation.
  • Safety framework: Sessions are held at designated Government facilities under trained Medical Officers, with sites linked to 24×7 centres for management of Adverse Events Following Immunization (AEFI).
  • Governance significance: The scale achieved in nine months tests Centre-State coordination, frontline health capacity and digital tracking infrastructure.
Detailed analysis

The full analysis is in the app

This page is the summary. The detailed analysis of this story covers:

What is the statusWhat are the challengesWhat measuresWhat lies aheadImportant Data PointsBackgroundKey Important PointsPrelims RelatedMains RelatedImportant WordsKey conceptsPrevious year questions
Open in Quorum IAS